sitting this one out

I'm sitting on the sidelines on this Quarterly.

As quarterlies merely state the condition of the company, as seen with previous quarterlies, the lack of prior updates to excite the market with encouraging sales figures is a bit worrying.

I'll see you all on the other end of the rapids next week.

I'm sure the management are doing their best in a tough market, I don't expect a disaster, just lukewarm sales figures slightly better than the last quarterly.

Though, I hope for the sake of Abas and other patient longtermers that I am caught completely by surprise.